
Medicine and Health
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
S. S. Leventhal, T. Bisom, et al.
Discover groundbreaking research on the Crimean-Congo Hemorrhagic Fever Virus, revealing how a self-replicating RNA vaccine induces neutralizing antibodies and protective immunity through TRIM21. This exciting study by Shanna S Leventhal and colleagues sheds new light on the mechanisms of protection against this lethal virus.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.